Publications by authors named "H Shimpo"
: Routine activated partial thromboplastin time (APTT) and prothrombin time (PT) measurements do not indicate hypercoagulability in patients with acute myocardial infarction (AMI) and acute cerebral infarction (ACI). : Hypercoagulability in patients with AMI or ACI was evaluated using a clot waveform analysis of the APTT or a small amount of tissue factor activation assay (sTF/FIXa). In the CWA, the derivative peak time (DPT), height (DPH), width (DPW), and area the under the curve (AUC) were evaluated.
View Article and Find Full Text PDF: FVIII reagent activity varies across different assays, as well as activated partial thromboplastin time (APTT) reagents. The hemostatic ability of various FVIII reagents was examined via clot waveform analysis (CWA). : APTT was measured using 12 APTT reagents, a small amount of tissue factor-induced FIX activation (sTF/FIXa) and a small amount of thrombin time (sTT) in order to examine 10 FVIII reagents and reference plasma (RP) using CWA.
View Article and Find Full Text PDFArticle Synopsis
- * The analysis involved 17 patients, divided into two groups: biventricular repair (BVR) and univentricular repair (UVR) candidates, comparing their echocardiogram data before and after surgical interventions.
- * Results showed significant LVOT growth in BVR candidates and notable increases in both the neo-aortic valve and neo-ascending aorta measurements for UVR candidates, indicating positive outcomes from the bPAB procedure prior to arch
Although hepatocellular carcinoma (HCC) is frequently associated with thrombosis, it is also associated with liver cirrhosis (LC) which causes hemostatic abnormalities. Therefore, hemostatic abnormalities in patients with HCC were examined using a clot waveform analysis (CWA). Hemostatic abnormalities in 88 samples from HCC patients, 48 samples from LC patients and 153 samples from patients with chronic liver diseases (CH) were examined using a CWA-activated partial thromboplastin time (APTT) and small amount of tissue factor induced FIX activation (sTF/FIXa) assay.
View Article and Find Full Text PDFPurpose: The processes and methods of treating and polishing additive-manufactured (AMed) cobalt-chromium (Co-Cr) alloy clasps were assessed in vitro to determine their suitability for constant clinical use and the reduction of dental technician work.
Methods: AMed Aker clasps were fabricated by selective laser sintering of approximately 50 μm Co-Cr alloy powders. After the nodules and fins on the inner surface of the AMed clasps were removed and morphological correction was performed, a dental technician manually polished the clasps as a control.